thinkgenetic.comThinkGenetic uses AI to find rare disease

patients Corporate Information | Press & Media | For Investors ThinkGenetic Finding Patients At Risk for Rare Disease Home Solutions FindEHR™ FindSM™ Research Medical Publications Technical Research About Team and Board Partners News & Events Press Releases Latest News Videos Events Contact Request a Demo Combining clinical expertise & AI to find patients at risk for rare disease Watch this 2-minute video to see why MIT and Horizon voted ThinkGenetic best in the world Awards & Accolades Applying validated rare disease algorithms to millions of Electronic Health Records in a regulatory-compliant manner, uncovering at-risk or diagnosed individuals hidden in plain sight Learn More Creating an interactive patient risk-assessment module for integration into your website, providing insights on undiagnosed consumers concerned about their risk level Learn More We find rare. ThinkGenetic, Inc. is an award-winning digital health company specializing in finding individuals at risk of rare and genetic conditions. Leveraging validated algorithms and extensive expertise in rare diseases, ThinkGenetic offers digital solutions to detect patients for evaluation, treatment, and clinical trials, while ensuring compliance with important PHI (Protected Health Information) regulations. The company serves clients in biopharma, research institutions, healthcare practice settings, and advocacy organizations. We empower our clients to uncover individuals who may be vulnerable and provide essential resources to support critical healthcare decisions using the power of AI technology. Learn more about ThinkGenetic Our solutions are sensitive and specific enough to flag patients at increased risk and provide de identified HIPAA compliant data to clients CROSS-DEPARTMENT SOLUTIONS FOR YOUR ORGANIZATION Speed detection time for genetic and rare conditions Reduce the chance of diagnostic error Educate providers on sponsored testing, trials & treatment Gain important data for your marketing efforts Learn more about our Solutions Validated Approach ThinkGenetic’s unparalleled, masterclass level of knowledge and expertise provides the foundation to help our clients overcome challenges in rare diseases. Together, our results-oriented solutions, provide a robust library of research on our unique approach. This loop of refinement supports the continuous validation of our state-of-the-art proprietary algorithms. See our research results Collaborating to make an impact in rare disease The project with ThinkGenetic has sparked significant interest within our organization. As a result, we have scheduled a wider, regional roll-out across our Growth & Emerging Markets Business Unit which spans almost 50 countries. Additionally, within the wider Takeda community, our global colleagues are considering its implementation in other countries and regions.” Marie Gray, Regional Franchise Head Rare Metabolic Disease & Neuroscience Takeda Read more Your entrepreneurial approach to leveraging genetic-sequencing data to proactively identify patients at risk for a rare condition has the potential to improve the quality of life for millions of patients and their families. I applaud and respect the drive and passion it takes to bring your idea to fruition. On behalf of rare disease patients around the world, thank you.” Tim Walbert, chairman, president and chief executive officer, Horizon Therapeutics Read more As a company committed to helping patients with rare genetic disorders, PTC Therapeutics is excited to partner with ThinkGenetic and GRN. Reaching the right diagnosis can be a long and difficult process for patients with rare diseases. We’re hopeful this partnership will help shorten that journey for patients, their families, and healthcare providers.” Bruce Braughton, Senior Vice President and General Manager, PTC Therapeutics Read more Explore the latest news & insights. Read Our Blog [Audio] A Late Diagnosis of Cutis Laxa and the Creation of ThinkGenetic March 6, 2024 Interested in hearing about the journey behind ThinkGenetic Inc.’s mission to accelerate rare disease diagnosis? Tune in to the recent audio interview with Kristina Inman on the Grey Genetics Patient Stories Podcast as she speaks with ThinkGenetic Inc. founder, Dave Jacob. In this insightful conversation, Dave delves into his diagnosis of Cutis Laxa, a rare… Elevating Awareness and Empathy: Rare Disease Day 2024 February 29, 2024 By Michael Bray, PhD, MS, CGC, Clinical Genetic Data Specialist Our genetic makeup is a gift that we receive, a blueprint of our individuality, yet for some, it harbors complexities that lead to rare diseases. As we observe Rare Disease Day on February 29, 2024, it’s crucial to reflect on the journey of the 300… ThinkGenetic’s Presence at the 20th Annual WORLDSymposium™ 2024 January 17, 2024 ThinkGenetic is pleased to announce the participation of its new Chief Executive Officer, Ruth Jacob O’Keefe, alongside the continued presence of Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, at the upcoming 20th Annual WORLDSymposium™. Scheduled to take place at the Manchester Grand Hyatt San Diego, San Diego, CA, USA, from February 4 to 9,… Our Clients Together let’s systematically accelerate detecting at-risk individuals. Request a Demo Solutions FindEHR™ FindSM™ Resources Contact Research FAQs About ThinkGenetic Team Board Investors Careers Legal Disclaimers Privacy Policy " * " indicates required fields Email Address * Comments This field is for validation purposes and should be left unchanged. Δ Facebook Instagram LinkedIn YouTube ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information . ©2024 ThinkGenetic. All...